IRIS
ANGARANO, Gioacchino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.379
EU - Europa 4.479
AS - Asia 1.587
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 8
OC - Oceania 3
Totale 25.478
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.362
CN - Cina 1.404
DE - Germania 1.271
SE - Svezia 850
UA - Ucraina 804
IT - Italia 454
FI - Finlandia 440
GB - Regno Unito 326
FR - Francia 78
RU - Federazione Russa 68
IN - India 64
BE - Belgio 57
IE - Irlanda 48
VN - Vietnam 48
MK - Macedonia 25
IR - Iran 22
CA - Canada 12
EU - Europa 10
RO - Romania 10
TR - Turchia 10
GE - Georgia 9
NL - Olanda 8
GR - Grecia 7
PL - Polonia 7
HK - Hong Kong 6
ID - Indonesia 5
AT - Austria 4
HU - Ungheria 4
RS - Serbia 4
ZA - Sudafrica 4
AU - Australia 3
BR - Brasile 3
ES - Italia 3
MX - Messico 3
AR - Argentina 2
AZ - Azerbaigian 2
BH - Bahrain 2
EG - Egitto 2
HR - Croazia 2
JO - Giordania 2
KE - Kenya 2
KH - Cambogia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MY - Malesia 2
TN - Tunisia 2
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ET - Etiopia 1
IL - Israele 1
IM - Isola di Man 1
IQ - Iraq 1
JM - Giamaica 1
KR - Corea 1
NG - Nigeria 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 25.478
Salva come PNG Salva come JPEG
Città #
Fairfield 2.754
Woodbridge 2.030
Jacksonville 1.876
Chandler 1.702
Houston 1.486
Ashburn 1.228
Seattle 1.123
Wilmington 1.010
Cambridge 913
Ann Arbor 853
Nyköping 579
Lawrence 465
Roxbury 463
Nanjing 450
Des Moines 287
New York 252
Beijing 236
Princeton 231
Boardman 219
Shenyang 127
Hebei 122
Inglewood 119
Dearborn 111
Nanchang 111
San Diego 111
Bari 108
Jiaxing 70
Tianjin 69
Brooklyn 63
Dublin 47
Dong Ket 46
Brussels 42
Pune 40
London 39
Changsha 36
Paris 29
Hefei 28
Taranto 27
Washington 22
Auburn Hills 21
Falls Church 21
Norwalk 21
Guangzhou 20
Helsinki 20
Jinan 20
Redwood City 19
Rome 18
Zhengzhou 18
Kunming 17
Los Angeles 15
San Mateo 15
Ardabil 14
Prilep 14
Kilburn 13
Milan 13
Ningbo 13
Leawood 12
Hangzhou 8
Indiana 7
Monmouth Junction 7
Taizhou 7
Bergamo 6
Naples 6
Amsterdam 5
Augusta 5
Chiswick 5
Redmond 5
San Francisco 5
Skopje 5
Tappahannock 5
Vignola 5
Brescia 4
Budapest 4
Florence 4
Grafing 4
Hounslow 4
Islington 4
Palermo 4
Triggiano 4
Weimar 4
Alcamo 3
Athens 3
Catania 3
Chengdu 3
Chicago 3
Clearwater 3
Delhi 3
Detroit 3
Edinburgh 3
Martina Franca 3
Modena 3
Modugno 3
Monza 3
Muizenberg 3
Mumbai 3
Napoli 3
New Bedfont 3
New Delhi 3
Prescot 3
Stockholm 3
Totale 20.005
Salva come PNG Salva come JPEG
Nome #
Influence of HLA-B18 on liver fibrosis progression in a cohort of HIV/HCV coinfected individuals 171
Economic evaluation of HIV treatments: The I.CO.N.A. cohort study 146
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 138
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART 126
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 126
Access to HAART in HIV-Infected Immigrants: A Retrospective Multicenter Italian Study 122
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. 122
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 116
Co-receptor switch during HAART is independent of virological success 115
HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ? 115
Chronic Inflammation in a Long-Term Cohort of HIV-Infected Patients According to the Normalization of the CD4:CD8 Ratio 114
Cryptosporidiosis in the acquired immunodeficiency syndrome: a case report 113
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 113
Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/HIV coinfection 110
Improved virological outcome in non-B patients: a possible role for baseline coreceptor tropism 109
HIV-RNA decay in paired blood and semen samples of subjects receiving their first dolutegravir-based ART regimen 109
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 105
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: data from the Icona Foundation cohort. 104
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 102
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 102
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 101
Cerebrospinal fluid compartmentalization of HIV-1 and correlation with plasma viral load and blood–brain barrier damage 101
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 100
The elderly and direct antiviral agents: Constraint or challenge? 99
Prevalence of urinary schistosomiasis in migrants in Apulia, a region of southern Italy, in the years 2006-2016 98
Variability OF HIV-1 V2 env domain for integrin binding: Clinical correlates 98
Comment on: Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection 96
Intrathecal immune response in human immunodeficiency virus infection 95
An outbreak of HIV-1 BC recombinants in Southern Italy 95
Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort). 95
Hepatitis B virus markers, alpha-fetoprotein and survival in fulminant viral hepatitis 94
Access to health services for undocumented immigrants in Apulia. 94
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia 94
Persistence of e antigen as prognostic marker in acute hepatitis B 93
Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin. 93
Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies 93
Sphingomonas paucimobilis outbreak in a dialysis room: Case report and literature review of an emerging healthcare associated infection 93
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 93
Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study 92
HIV-1 biological phenotype and predicted coreceptor usage based on V3 loop sequence in paired PBMC and plasma samples 92
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA <50 cp/mL 92
HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5years 91
An observational comparison of first-line combination antiretroviral treatment (cART) with 2NRTI and ATV/r or DRV/r in HIV-infected patients in Italy 91
HIV infection and protease genetic diversity in a rural area of the Southern Central African Republic 91
Limiting severe outcomes and impact on intensive care units of moderate-intermediate 2009 pandemic influenza: role of infectious diseases units. 91
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 91
Radioimmunoassay diagnosis of hepatitis type A 90
CD4 and CD4/CD8 ratio progression in HIV-HCV infected patients after achievement of SVR 89
Premature lesions of the carotid vessels in HIV-1 infected patients treated with protease inhibitors 88
Cardiovascular risk factors in patients on long-term treatment with nevirapine- or efavirenz-based regimens 88
Effects of Therapy with Maraviroc on the Carotid Intima Media Thickness in HIV-1/HCV Co-infected Patients 88
Risk of AIDS in HIV seroconverters: a comparison between intravenous drug users and homosexual males 87
A cyanobacterium-like body found in the stools of an HIV+ patient with diarrhoea 87
Genotypic analysis of the protease and reverse transcriptase of non-B HIV type 1 clinical isolates from naïve and treated subjects 87
Renal function changes in HCV-infected patients with chronic kidney disease during and after treatment with direct antiviral agents 86
Parkinsonism in a patient with AIDS and cerebral opportunistic granulomatous lesions 85
Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection 85
Cryptococcal Meningitis 85
Difficulties in classifying a/g recombinants: methodological problems or genetic variability? 85
Epidemiological multicentric Italian society of infectious and tropical diseases study on prevalence of tropical diseases in hospitalized immigrants in Italy during 2002 85
Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients 85
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 85
Effects of HIV superinfection on HBV replication in a chronic HbsAg carrier with liver disease 84
Cell cultures from small amounts of heparinized whole blood enhance HIV-1 isolation rate 84
Adherence of hiv patients switching to emtricitabina+tenofovir disoproxil+rilpivirin. Real world evidence from italian administrative databases 84
Evolution of antiretroviral prescription and response over a period of 8 years: An Italian multicentre observational prospective cohort study 84
Hepatic encephalopathy in the course of anti-HCV therapy with paritaprevir/ritonavir, ombitasvir, dasabuvir and ribavirin 84
Local epidemics gone viral: Evolution and diffusion of the Italian HIV-1 recombinant form CRF60_BC 84
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 84
Peg-interferon alpha-2a versus Peg-interferon alpha-2b in nonresponders with HCV active chronic hepatitis: a pilot study 83
Detection of human T lymphotropic virus type II/b in human immunodeficiency virus type 1-coinfected persons in southeastern Italy 82
Reduced community viral load does not coincide with a reduction in the rate of new HIV diagnoses and recent infections: data from a region of southern Italy 82
Reproductive choice in individuals HIV-1 infected in South Eastern Italy 82
Splenic abscesses as a first manifestation of Crohn's disease: A case report 82
null 81
HIV-1 variability and progression to AIDS: a longitudinal study 81
Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir 81
Correlation between seroreactivity to HIV-1 V3 loop peptides and male-to female heterosexual transmission 80
Access to Health Services for Undocumented Immigrants in Apulia 80
Ciprofloxacin for treating cholera 80
HCV and diabetes: Towards a 'sustained' glycaemic improvement after treatment with DAAs? 80
Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users 79
Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART 79
V3 sequences and paired HIV isolates from 52 non-subtype B HIV type 1-infected patients 79
Mutational patterns of paired blood and rectal biopsies in HIV-infected patients on HAART 79
Are the proposed env mutations actually associated with resistance to maraviroc? 79
Risk of severe non AIDS events is increased among patients unable to increase their CD4 + T-cell counts >200+/μl despite effective HAART 79
Survival of Zidovudine-treated patients with AIDS compared with that of contemporary untreated patients 78
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group. 78
Familial clustering of HBV pre-C and pre-S mutants 77
Valore prognostico della neopterina nel siero di soggetti con infezione da HIV 77
Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-a 77
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 77
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 77
Immunological markers in HIV-infected pregnant and non-pregnant women 77
Incidence of tuberculosis among HIV-Infected patients receiving highly active antiretroviral therapy in Europe and North America 77
Frequent cervicovaginal shedding of HIV-1 in asymptomatic, non-severely immunodeficient women 76
Response of severe HIV-associated thrombocytopenia to highly active antiretroviral therapy including protease inhibitors 76
Rapid spread of HTLV-III infection among drug-addicts in Italy 76
Opportunistic parasitic infections of the intestinal tract in the era of highly active antiretroviral therapy: is the cd4+ count so important? 76
Totale 9.254
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.740
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.740
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.161 0 0 0 0 0 0 0 0 0 390 884 887
2019/20207.343 1.263 461 195 621 816 464 814 616 886 406 635 166
2020/20214.257 442 306 394 256 538 214 473 207 450 541 252 184
2021/20222.804 111 371 36 233 138 186 103 197 186 173 451 619
2022/20234.434 798 318 186 448 628 517 40 502 772 34 102 89
2023/20241.251 144 345 83 75 96 394 39 39 28 8 0 0
Totale 26.097